
Adial Pharmaceuticals, Inc. (ADIL) - Yahoo Finance
Find the latest Adial Pharmaceuticals, Inc. (ADIL) stock quote, history, news and other vital information to help you with your stock trading and investing.
ADIL Stock Price | Adial Pharmaceuticals Inc. Stock Quote (U.S.: …
5 days ago · ADIL | Complete Adial Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Adial Pharmaceuticals (ADIL) Stock Price & Overview
6 days ago · A detailed overview of Adial Pharmaceuticals, Inc. (ADIL) stock, including real-time price, chart, key statistics, news, and more.
Home - Adial Pharmaceuticals Inc.
Nov 26, 2025 · Adial is a clinical-stage biopharmaceutical company focused on the treatment and prevention of addictions and other unmet medical needs.
Adial Pharmaceuticals (ADIL) Stock Forecast & Price Target
2 days ago · ADIL's current price target is $1.50. Learn why top analysts are making this stock forecast for Adial Pharmaceuticals at MarketBeat.
Adial Pharmaceuticals Inc (ADIL) Stock Price & News - Google
Get the latest Adial Pharmaceuticals Inc (ADIL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
ADIL Stock Price Quote | Morningstar
2 days ago · See the latest Adial Pharmaceuticals Inc stock price (ADIL:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
ADIL: Adial Pharmaceuticals Inc - Stock Price, Quote and News - CNBC
Get Adial Pharmaceuticals Inc (ADIL:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Adial Pharmaceuticals, Inc Common Stock (ADIL) - Nasdaq
Nov 1, 2025 · Discover real-time Adial Pharmaceuticals, Inc Common Stock (ADIL) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions.
ADIL Adial Pharmaceuticals, Inc. - Seeking Alpha
A high-level overview of Adial Pharmaceuticals, Inc. (ADIL) stock. View (ADIL) real-time stock price, chart, news, analysis, analyst reviews and more.